<DOC>
	<DOCNO>NCT01589094</DOCNO>
	<brief_summary>The purpose study find standard chemotherapy ( gemcitabine cisplatin ) give dose-dense treatment schedule ( less time treatment ) help shrink tumor well standard chemotherapy give standard treatment schedule patient undergoes surgery bladder cancer .</brief_summary>
	<brief_title>Neoadjuvant Dose Dense Gemcitabine Cisplatin ( DD GC ) In Patients With Muscle-Invasive Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Muscle invasive urothelial carcinoma bladder histologically confirm MSKCC participate site ( ( Urothelial carcinoma invade prostatic stroma histologic muscle invasion allow , provide extent disease confirm via image and/or EUA . ) Clinical stage T2T4a N0/X M0 disease Medically appropriate candidate radical cystectomy , per MSKCC participate site Karnofsky Performance Status ≥ 70 % Age ≥ 18 year age Required Initial Laboratory Values : Absolute Neutrophil Count ≥ 1000 cells/mm3 Platelets ≥ 100,000 cells/mm3 Hemoglobin ≥ 9.0g/dL Bilirubin ≤ 1.5 upper limit normal ( ULN ) institution Aspartate transaminase ( AST ) alanine transaminase ( ALT ) ≤ 2.5 x ULN institution Alkaline phosphatase ≤ 2.5 x ULN institution Serum creatinine ≤ 1.5 mg/dL Estimated glomerular filtration rate ≥ 60 ml/min/1.73m2 use CKDEPI equation : eGFR = 141 x min ( Scr/k , 1 ) x max ( Scr/k , 1 ) 1.209 x 0.993Age x 1.018 [ female ] x 1.159 [ black ] Scr serum creatinine , k 0.7 female 0.9 male , 0.329 female 0.411 male , min indicate minimum Scr/k 1 , max indicate maximum Scr/k 1 If female childbearing potential , pregnancy test negative Prior systemic chemotherapy ( prior intravesical therapy allow ) Prior radiation therapy bladder Evidence NYHA functional class III IV heart disease Serious intercurrent medical psychiatric illness , include serious active infection Preexisting sensory grade ≥ 2 neuropathy Preexisting grade ≥ 2 hearing loss Major surgery radiation therapy &lt; 4 week start study treatment Concomitant use investigational drug Any follow within 6 month prior study drug administration : myocardial infarction , severe/unstable angina , coronary/peripheral artery bypass graft , symptomatic congestive heart failure , cerebrovascular accident , transient ischemic attack Ongoing cardiac dysrhythmias NCI CTCAE Version 4.0 grade ≥ 2 Known human immunodeficiency virus ( HIV ) acquire immunodeficiency syndrome ( AIDS ) relate illness active infection Concurrent treatment another clinical trial ; supportive care trial nontreatment trial , e.g . QOL , allow Pregnancy breastfeed . Patients must surgically sterile , postmenopausal , must agree use effective contraception period therapy . The definition effective contraception base judgment principal investigator designate associate . Male patient must surgically sterile agree use effective contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>CISPLATIN</keyword>
	<keyword>GEMCITABINE</keyword>
	<keyword>GM-CSF</keyword>
	<keyword>radical cystectomy</keyword>
	<keyword>12-071</keyword>
</DOC>